8 completed, 2 unknown, 1 active not recruiting. 4 Phase 2, 3 Not applicable, 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Not applicable | 3 | Completed 2, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Carotid Intimal Medial Thickness 1: new trials by email Literature Review of Carotid Intimal Medial Thickness 1 trials Research Report on Carotid Intimal Medial Thickness 1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Perspective, Self-control Study on the Progression of Carotid Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up PD-1 immune checkpoint blockades - Plaque, Atherosclerotic, Immune Checkpoint Inhibitors | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 50 | 2021-10-08 | 2021-11-17 | |
| Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy Modified Atkins or Ketogenic Diet - Hypercholesterolemia, Carotid Intimal Medial Thickness 1 | Active not recruiting | Johns Hopkins University | 105 | 2016-03-01 | 2026-09-08 | |
| Modulation of Lactase Expression by a New PPARgamma Ligand in Duodenal Biopsies GED - Lactose Intolerance | Not applicable | Completed | University Hospital, Lille | 22 | 2015-07-16 | 2018-10-17 |
| Preventing Squamous Cell Skin Cancer Pioglitazone - Squamous Cell Carcinoma of the Skin | Phase 2 | Completed | University of Rochester | 12 | 2014-11-01 | 2020-06-23 |
| PERIODONTITIS AND VASCULAR DYSFUNCTION Intensive Periodontal Treatment, Control Periodontal Treatment - Periodontitis, Intimal Medial Thickness of Internal Carotid Artery | Not applicable | Completed | University College, London | 190 | 2013-04-16 | 2021-01-25 |
| Assessing the Effects of Alfacalcidol Intake on Expression of Involed Gene in Metabolism in Obese Subjects Placebo, Alfacalcidol - Obesity | Not applicable | Unknown | Tehran University of Medical Sciences | 94 | 2012-01-01 | 2012-12-27 |
| Effects of Lutein Supplementation on Subclinical Atherosclerosis Placebo, Lutein group, Combination group - Carotid Atherosclerosis, Carotid Intimal Medial Thickness 1 | Phase 2 / Phase 3 | Completed | Peking University | 192 | 2010-06-01 | 2013-07-22 |
| Changes of Biomarkers in Response to Training and Antioxidant Treatment Vitamin C, Vitamin E, Antioxidant treatment - Obesity, Type 2 Diabetes | Phase 1 | Completed | University of Leipzig | 40 | 2008-03-01 | 2010-01-20 |
| Placebo Controlled Dose-Response Study of Rivoglitazone in Type 2 Diabetes Rivoglitazone HCl, rivoglitazone HCl, Placebo - Type 2 Diabetes | Phase 2 | Completed | Daiichi Sankyo Co., Ltd. | 250 | 2007-07-01 | 2009-03-02 |
| Pioglitazone Treatment in Polycystic Ovary Syndrome pioglitazone - Polycystic Ovary Syndrome | Phase 4 | Completed | Odense University Hospital | 30 | 2002-09-01 | 2008-09-26 |
| Treatment of Nonalcoholic Steatohepatitis With Pioglitazone Pioglitazone - Fatty Liver, Nonalcoholic Steatohepatitis | Phase 2 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 30 | 2001-03-01 | 2008-03-04 |
Obesity (3) · Diabetes Mellitus, Type 2 (2) · Insulin Resistance (2) · Atherosclerosis (1) · Carcinoma, Squamous Cell (1) · Cardiovascular Diseases (1) · Carotid Artery Diseases (1) · Carotid Stenosis (1) · Cerebrovascular Disorders (1) · Coronary Disease (1) · Diabetes Mellitus (1) · Epilepsy (1) · Fatty Liver (1) · Fibrosis (1)
Nutritional and Metabolic Diseases (7) · Metabolic Diseases (6) · Pathological Conditions, Signs and Symptoms (5) · Endocrine System Diseases (4) · Glucose Metabolism Disorders (4) · Signs and Symptoms (4) · Body Weight (3) · Brain Diseases (3) · Central Nervous System Diseases (3) · Nervous System Diseases (3) · Nutrition Disorders (3) · Overnutrition (3) · Overweight (3) · Vascular Diseases (3) · Arterial Occlusive Diseases (2)
Pioglitazone (3) · Ascorbic Acid (1) · Corn Oil (1) · Diet, Ketogenic (1) · Vitamin E (1) · alfacalcidol (1)
Daiichi Sankyo Co., Ltd. (1) · Johns Hopkins University (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Odense University Hospital (1) · Peking University (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Tehran University of Medical Sciences (1) · University College, London (1) · University Hospital, Lille (1) · University of Leipzig (1) · University of Rochester (1)
China (2) · United States (2) · Denmark (1) · France (1) · Germany (1) · Iran (1) · Japan (1) · United Kingdom (1)
Alice P. Pentland, M.D. (1) · Arash Hossein-nezhad, MD, PhD (1) · Dorte Glintborg, MD (1) · Jianan Wang, MD, PhD (1) · John Deanfield, MD (1) · Khadijeh Mirzaei, Ms (1) · Mackenzie C Cervenka, MD (1) · Pierre Desreumaux, MD, PhD (1) · Xiaoming Lin, M.M. (1)
PMID 12468791, PMID 12706187, PMID 18544618, PMID 19433800, PMID 21209881, PMID 21774709, PMID 22541275, PMID 22999793, PMID 23211475, PMID 24572452, PMID 26493239, PMID 27529295, PMID 30954372, PMID 33487129, PMID 34107730